MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation

Active, not recruitingOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

August 22, 2019

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Brain Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

PROCEDURE

Magnetic Resonance Imaging

Undergo functional MRI

PROCEDURE

Multiparametric Magnetic Resonance Imaging

Undergo multiparametric MRI

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER